Loring Wolcott & Coolidge Fiduciary Advisors LLP Boston Scientific Corp Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q3 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,352 shares of BSX stock, worth $121,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,352
Previous 1,233
9.65%
Holding current value
$121,680
Previous $94,000
20.21%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BSX
# of Institutions
1,539Shares Held
1.19BCall Options Held
6.79MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$11.8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.66 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.4 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.95 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $129B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...